Infection with hepatitis C virus in hemodialysis patients: An overview of the diagnosis and prevention rules within a hemodialysis center (Review).
HCV infection
chronic kidney disease
hemodialysis
prevention
screening
Journal
Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
31
01
2020
accepted:
03
03
2020
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
9
6
2020
Statut:
ppublish
Résumé
Increase in the number of patients with chronic kidney disease (CKD) calls for improved management of these patients. In stage 5 CKD, when the initiation of renal replacement therapy (RRT) becomes necessary, there is an increase in the infection risk of the patients and immunological tests for hepatitis C virus (HCV) detection turn positive at an alarmingly higher rate compared to general population. With the introduction into clinical practice of diagnostic tests, the increased prevalence of HCV among CKD patients has been known since the 1990s. Also, the negative impacts of HCV infection on CKD evolution as well as the unfavorable evolution of grafts received by HCV infected patients are known. Chronic hemodialysis patients are a category of patients whose risk of HCV infection is substantial. Currently, in the hemodialysis centers, at the base of the transmission of HCV infection there are a multitude of factors. Infection with HCV has a different impact on patient with end-stage renal disease (ESRD). Comorbidities in this case have significant sources of mortality and morbidity. It was proven that the post transplantations problems were prevented and mortality was reduced for patients who were diagnosed with HCV and in whom the infection was treated before the kidney transplant (KT). Consequently, early detection of the infection and the application of specific treatment has a considerable impact on the outcome of the patients. Another important component of the management of HCV infection in the chronic hemodialysis patients is the prevention of the infection transmission by applying specific methods.
Identifiants
pubmed: 32509002
doi: 10.3892/etm.2020.8606
pii: ETM-0-0-8606
pmc: PMC7271692
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
109-116Informations de copyright
Copyright: © Timofte et al.
Références
Nephrol Dial Transplant. 1996 Oct;11(10):2017-22
pubmed: 8918716
World J Gastroenterol. 2014 Mar 21;20(11):2948-54
pubmed: 24659885
Clin Liver Dis. 2005 Aug;9(3):383-98, vi
pubmed: 16023972
Nephron Clin Pract. 2011;117(4):c328-32
pubmed: 21051906
Semin Dial. 2005 Jan-Feb;18(1):52-61
pubmed: 15663766
Kidney Blood Press Res. 2014;39(4):260-71
pubmed: 25171295
Nephron Clin Pract. 2011;118 Suppl 1:c27-70
pubmed: 21555900
J Bras Nefrol. 2019 Oct-Dec;41(4):539-549
pubmed: 30806444
Dig Dis Sci. 2006 Aug;51(8):1420-5
pubmed: 16868830
BMC Nephrol. 2018 Mar 15;19(1):66
pubmed: 29544451
BMC Infect Dis. 2013 Feb 07;13:76
pubmed: 23391009
J Med Virol. 2006 Feb;78(2):185-91
pubmed: 16372289
Infect Control Hosp Epidemiol. 2009 Sep;30(9):900-3
pubmed: 19642900
Hemodial Int. 2013 Oct;17(4):532-41
pubmed: 23072424
BMC Infect Dis. 2019 Jul 23;19(1):655
pubmed: 31337339
Hepat Mon. 2012 Jun;12(6):369-71
pubmed: 22879825
Indian J Med Res. 2014 Jul;140(1):123-9
pubmed: 25222787
Ann Intern Med. 2000 Feb 15;132(4):296-305
pubmed: 10681285
ISRN Nephrol. 2012 Oct 31;2013:395467
pubmed: 24967226
MMWR Recomm Rep. 2001 Apr 27;50(RR-5):1-43
pubmed: 11349873
Infect Control Hosp Epidemiol. 2016 Feb;37(2):125-33
pubmed: 26573412
N Engl J Med. 2001 Jul 5;345(1):41-52
pubmed: 11439948
Nephrol Dial Transplant. 1999 Jan;14(1):40-5
pubmed: 10052474
BMC Infect Dis. 2012 Oct 20;12:265
pubmed: 23082935
Antiviral Res. 2003 Oct;60(2):129-34
pubmed: 14638409
Clin Nephrol. 2001 Jun;55(6):477-81
pubmed: 11434360
Infect Control Hosp Epidemiol. 2005 Sep;26(9):752-60
pubmed: 16209381
Am J Kidney Dis. 2010 Aug;56(2):371-8
pubmed: 20570422
Infect Control Hosp Epidemiol. 2016 Feb;37(2):134-9
pubmed: 26510471
Nephrol Dial Transplant. 2010 Jul;25(7):2047-9
pubmed: 20466682
Semin Dial. 2013 Jul-Aug;26(4):439-46
pubmed: 23859188
Nephrol Dial Transplant. 2005 Aug;20(8):1662-9
pubmed: 15905194
Korean J Intern Med. 2018 Jul;33(4):670-678
pubmed: 29961309
Kidney Int. 2004 Jun;65(6):2335-42
pubmed: 15149347
Kidney Int Suppl (2011). 2018 Oct;8(3):91-165
pubmed: 30675443
Am J Kidney Dis. 2001 May;37(5):1004-10
pubmed: 11325683
Hepatology. 2005 Oct;42(4):962-73
pubmed: 16149085
J Viral Hepat. 2020 Mar;27(3):233-234
pubmed: 31652366
J Hepatol. 2014 Nov;61(1 Suppl):S58-68
pubmed: 25443346
Saudi J Gastroenterol. 2012 Sep;18 Suppl:S1-32
pubmed: 23006491
Ann Intern Med. 2019 Oct 1;171(7):496-504
pubmed: 31546256
Int J Artif Organs. 2015 Sep;38(9):471-80
pubmed: 26449566
Kidney Int. 1998 Apr;53(4):1022-5
pubmed: 9551413
Curr Health Sci J. 2018 Apr-Jun;44(2):107-112
pubmed: 30746156
Nephrol Dial Transplant. 2011 Jul;26(7):2309-16
pubmed: 21097646
J Med Virol. 2005 Sep;77(1):70-6
pubmed: 16032714
Kidney Int. 2018 Oct;94(4):663-673
pubmed: 30243313
Semin Dial. 2019 Mar;32(2):127-134
pubmed: 30569604
Nephrol Dial Transplant. 2002;17 Suppl 7:72-87
pubmed: 12386234
BMC Nephrol. 2019 Oct 28;20(1):388
pubmed: 31656166